date:Dec 24, 2012
business development director said Astral's remaining 25 percent interest will be in a larger specialty premix business.
The decision to sell a portion of Astral's interest in this business was taken to allow Cargill's animal nutrition business to invest in the redevelopment of the NuTec facility, and simultaneously expand premix sales into African markets, Arnold said.